Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling regardless of KRAS or BRAF…

Overview of attention for article published in Oncotarget, July 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 8 news outlets
blogs: 6 blogs
twitter: 5 X users

facebook: 1 Facebook page
reddit: 1 Redditor
video: 1 YouTube creator

Summary News Blogs X Facebook Reddit YouTube

So far, Altmetric has seen 1 YouTube video.

Regorafenib and TAS102 Synergize Against Gastrointestinal Cancers | Oncotarget

User Oncotarget on YouTube, 02 Jul 2024

Oncotarget #published this #research paper on July 2, 2024 in Volume 15, entitled, “Regorafenib synergizes with TAS102 against…